Skip to main content
SpringerLink
Log in
Book cover

Clinical Approach to Infection in the Compromised Host pp 347–366Cite as

Herpes Group Virus Infections in the Compromised Host

  • Chapter

  • 44 Accesses

Abstract

Disorders of cell-mediated immunity are frequently associated with herpesvirus infections that are occasionally severe and prolonged. Such infections can be primary, as when the renal transplant recipient who is seronegative for cytomegalovirus (CMV) is grafted with a kidney from a seropositive donor. More often, they result from reactivation of latent virus, as when the patient with Hodgkin disease develops zoster following irradiation and chemotherapy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Crosby DL, Jones JH, Sussman M: Herpetic naso-oral ulcers after renal transplantation. Lancet 2:1191, 1969.

    Article  PubMed  CAS  Google Scholar 

  2. Anuras S, Summers R: Fulminant herpes simplex hepatitis in an adult: Report of a case in a renal transplant recipient. Gastroenterology 70:425–428, 1976.

    PubMed  CAS  Google Scholar 

  3. Rand KH, Rassmussen LE, Pollard RB, et al: Cellular immunity and herpesvirus infections in cardiac transplant patients. N Engl J Med 296:1372–1377, 1977.

    Article  PubMed  CAS  Google Scholar 

  4. Pass RF, Long WK, Whitley RJ, et al: Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: Role of source of kidney. J Infect Dis 137:556–563, 1978.

    Article  PubMed  CAS  Google Scholar 

  5. Cheeseman SH, Rubin RH, Stewart JA, et al: Controlled clinical trial of prophylactic human leukocyte interferon in renal transplantation: Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med 300:1345–1349, 1979.

    Article  PubMed  CAS  Google Scholar 

  6. Muller SA, Herrman EC Jr, Winkelmann RK: Herpes simplex infections in hematologic malignancies. Am J Med 52:102–114, 1972.

    Article  PubMed  CAS  Google Scholar 

  7. Faden HS, Bybee BL, Overall JC Jr, et al: Disseminated herpes virus hominis infection in a child with acute leukemia. J Pediatr 90:951–953, 1977.

    Article  PubMed  CAS  Google Scholar 

  8. Becker WB, Kipps A, McKenzie D: Disseminated herpes simplex virus infection—its pathogenesis based on viro-logical and pathological studies in 33 cases. Am J Dis Child 115:1–8, 1968.

    PubMed  CAS  Google Scholar 

  9. Wheeler CE Jr, Abele DC: Eczema herpeticum, primary and recurrent. Arch Dermatol 93:162–173, 1966.

    Article  PubMed  Google Scholar 

  10. Foley FD, Greenawald KA, Nash G, et al: Herpes virus infections in burned patients. N Engl J Med 282:652–656, 1970.

    Article  PubMed  CAS  Google Scholar 

  11. Sutton AL, Smithwick EM, Seligman SJ, et al: Fatal disseminated herpesvirus hominis type 2 infection in an adult with associated thymic dysplasia. Am J Med 56:545–553, 1974.

    Article  PubMed  CAS  Google Scholar 

  12. Siegal EP, Lopez C, Hammer GS, et al: Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 305:1439–1444, 1981.

    Article  PubMed  CAS  Google Scholar 

  13. Nash G: Necrotizing tracheobronchitis and bronchopneumonia consistent with herpetic infection. Hum Pathol 3:283–291, 1972.

    Article  PubMed  CAS  Google Scholar 

  14. Ramsey PG, Fife KH, Hackman RC, et al: Herpes simplex virus pneumonia—clinical, virologic, and pathologic features in 20 patients. Ann Intern Med 97:813–820, 1982.

    PubMed  CAS  Google Scholar 

  15. Nash G, Ross JS: Herpetic esophagitis—a common cause of esophageal ulceration. Hum Pathol 5:339–345, 1974.

    Article  PubMed  CAS  Google Scholar 

  16. Warren KG, Brown SM, Wroblewska Z, et al: Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N Engl J Med 298:1068–1070, 1978.

    Article  PubMed  CAS  Google Scholar 

  17. Hirsch MS, Zisman B, Allison AC: Macrophages and age-dependent resistance to herpes simplex virus in mice. J Immunol 104:1160–1165, 1970.

    PubMed  CAS  Google Scholar 

  18. Linnavuori K, Hovi T: Restricted replication of herpes simplex virus in human monocyte cultures: Role of interferon. Virology 130:1–9, 1983.

    Article  PubMed  CAS  Google Scholar 

  19. Shore SL, Milgrom H, Wood PA, et al: Antibody-dependent cellular cytoxicity to target cells infected with herpes simplex viruses: Functional adequacy in the neonate. Pediatrics 59:22–28, 1977.

    PubMed  CAS  Google Scholar 

  20. Rasmussen LE, Jordan GW, Stevens DA, et al: Lymphocyte interferon production and transformation after herpes simplex infections in humans. J Immunol 112:728–736, 1974.

    PubMed  CAS  Google Scholar 

  21. Pazin GJ, Lam MT, Armstrong JA, et al: Interferon prevention of HSV reactivation. N Engl J Med 301:225–230, 1979.

    Article  PubMed  CAS  Google Scholar 

  22. Zisman B, Hirsch MS, Allison AC: Effects of anti-lymphocyte serum, anti-macrophage serum and silica on herpes simplex virus infection of mice. J Immunol 104:1155–1159, 1970.

    PubMed  CAS  Google Scholar 

  23. Thong YH, Vincent MM, Hensen SA, et al: Depressed specific cell mediated immunity to herpes simplex virus type 1 in patients with recurrent herpes labialis. Infect Immunol 12:76–80, 1975.

    CAS  Google Scholar 

  24. Kirchner H, Schwenteck M, Northoff H, et al: Defective in vitro lymphoproliferative responses to hepes simplex virus in natients with frequently recurring herpes infections during the disease-free interval. Clin Immunol Immunopathol 11:267–274, 1978.

    Article  PubMed  CAS  Google Scholar 

  25. Rasmussen LE, Jordan GW, Stevens DA: Lymphocyte interferon production and transformation after herpes simplex infections in humans. J Immunol 112:728–736, 1974.

    PubMed  CAS  Google Scholar 

  26. Sarai R, Burns WH, Laskin OL, et al: Acyclovir prophylaxis of herpes-simplex virus infections: A randomized, double-blind controlled trial in bone-marrow-transplant recipients. N Engl J Med 305:63–67, 1981.

    Article  Google Scholar 

  27. Sarai R, Ambinder RF, Burns WH, et al: Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia—a randomized, double-blind, placebo-controlled study. Ann Intern Med 99:773–776, 1983.

    Google Scholar 

  28. Gluckman E, Lotsberg J, Devergie A, et al: Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir. Lancet 2:706–708, 1983.

    Article  PubMed  CAS  Google Scholar 

  29. Wade JC, Newton B, Fluornoy N, et al: Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 100:823–828, 1984.

    PubMed  CAS  Google Scholar 

  30. Wade JC, Newton B, McLaren C, et al: Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation. Ann Intern Med 96:265–269, 1982.

    PubMed  CAS  Google Scholar 

  31. Chou S, Gallagher JG, Merigan TC: Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infections. Lancet 1:1392–1394, 1981.

    Article  PubMed  CAS  Google Scholar 

  32. Straus SE, Seidlin M, Takiff H, et al: Oral acyclovir to suppress recurring herpes simplex virus infections in immu-nodeficient patients. Ann Intern Med 100:522–524, 1984.

    PubMed  CAS  Google Scholar 

  33. Whitley RJ, Levin M, Barton N, et al: Infections caused by herpes simplex virus in the immunocompromised host: Natural history and topical acyclovir therapy. J Infect Dis 150:323–329, 1984.

    Article  PubMed  CAS  Google Scholar 

  34. Feldman S, Hughes WT, Daniel CB: Varicella in children with cancer: Seventy-seven cases. Pediatrics 56:388–397, 1975.

    PubMed  CAS  Google Scholar 

  35. Reboul F, Donaldson SS, Kaplan HS: Herpes zoster and varicella in children with Hodgkin’s disease—an analysis of contributing factors. Cancer 41:95–99, 1978.

    Article  PubMed  CAS  Google Scholar 

  36. Atkinson MK, Storb R, Prentice RL, et al: Analysis of late infections in eighty-nine long-term survivors of bone marrow transplantation. Blood 53:720–731, 1979.

    PubMed  CAS  Google Scholar 

  37. Lux SE, Johnston RB Jr, August CS, et al: Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med 282:231–236, 1970.

    Article  PubMed  CAS  Google Scholar 

  38. Sokal JE, Firat D: Varicella-zoster infection in Hodgkin’s disease. Am J Med 39:452–463, 1965.

    Article  PubMed  CAS  Google Scholar 

  39. Goffinett DR, Glatstein EJ, Merigan TC: Herpes zoster-varicella infections and lymphoma. Ann Intern Med 76:235–240, 1972.

    Google Scholar 

  40. Monfardini S, Bajetta E, Arnold CA, et al: Herpes zoster-varicella in malignant lymphomas. Eur J Cancer 11:51–57, 1975.

    PubMed  CAS  Google Scholar 

  41. Ruckdeschel JS, Schimpff SC, Smyth AC, et al: Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin’s disease. Am J Med 62:77–85, 1977.

    Article  PubMed  CAS  Google Scholar 

  42. Schimpff S, Serpick A, Stoler B, et al: Varicella-zoster infection in patients with cancer. Ann Intern Med 76:241–254, 1972.

    PubMed  CAS  Google Scholar 

  43. Wilson JF, Marsa GW, Johnson RE: Herpes zoster in Hodgkin’s disease. Cancer 29:461–465, 1972.

    Article  PubMed  CAS  Google Scholar 

  44. Mazur MH, Dolin R: Herpes zoster at the NIH: A 20 year experience. Am J Med 65:738–744, 1978.

    Article  PubMed  CAS  Google Scholar 

  45. Rifkind D: The activation of varicella-zoster virus infections by immunosuppressive therapy. J Lab Clin Med 68:463–474, 1966.

    PubMed  CAS  Google Scholar 

  46. Spencer ES, Anderson HK: Clinically evident, non-terminal infections with herpes viruses and the wart virus in immu-nosuppressed renal allograft recipients. Br Med J 3:251–254, 1970.

    Article  PubMed  CAS  Google Scholar 

  47. Naraqi S, Jackson GG, Jonasson O, et al: Prospective study of prevalence, incidence, and source of herpesvirus infections in patients with renal allografts. J Infect Dis 136:531–540, 1977.

    Article  PubMed  CAS  Google Scholar 

  48. Luby JP, Ramirez-Ronda C, Rinner S, et al: A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis 135:659–663, 1977.

    Article  PubMed  CAS  Google Scholar 

  49. Friedman-Kien AE, Lafleur FL, Gendler E, et al: Herpes zoster: A possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals. J Am Acad Dermatol 14:1023–1028, 1986.

    Article  PubMed  CAS  Google Scholar 

  50. Melbye M, Grossman RJ, Goedert JJ, et al: Risk of AIDS after herpes zoster. Lancet i:728–731, 1987.

    Article  Google Scholar 

  51. Jemsek J, Greenberg SB, Taber L, et al. Herpes zoster associated encephalitis: Cliniopathologic report of 12 cases and review of the literature. Medicine (Baltimore) 62:81–97, 1983.

    CAS  Google Scholar 

  52. Dolin R, Reichman RC, Mazur MH, et al: Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med 89:375–388, 1978.

    PubMed  CAS  Google Scholar 

  53. Feldman S, Chaudary S, Ossi M, et al: A viremic phase for herpes zoster in children with cancer. J Pediatr 91:597–600, 1977.

    Article  PubMed  CAS  Google Scholar 

  54. Stevens DA, Ferrington RA, Jordan GW, et al: Cellular events in zoster vesicles: Relation to clinical course and immune parameters. J Infect Dis 131:509–515, 1975.

    Article  PubMed  CAS  Google Scholar 

  55. Miller LH, Brunell PA: Zoster, reinfection or activation of latent virus? Am J Med 49:480–483, 1970.

    Article  PubMed  CAS  Google Scholar 

  56. Gershon AA, Krugman S: Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test. Pediatrics 56:1005–1008, 1975.

    PubMed  CAS  Google Scholar 

  57. Brunell PA, Gershon AA, Hughes WT, et al: Prevention of varicella in high risk children: A collaborative study. Pediatrics 56:718–722, 1972.

    Google Scholar 

  58. Meyers JD, Witte JJ: Zoster immune globulin in high-risk children. J Infect Dis 129:616–618, 1974.

    Article  Google Scholar 

  59. Wisnes R: Efficacy of zoster immunoglobulin in prophylaxis of varicella in high-risk patients. Acta Paediatr Scand 67:77–82, 1978.

    Article  Google Scholar 

  60. Orenstein WA, Heymann DL, Ellis RJ, et al: Prophylaxis of varicella in high-risk children: Dose-response effect of zoster immune globulin. J Pediatr 98:368–373, 1981.

    Article  PubMed  CAS  Google Scholar 

  61. Varicella-zoster immune globulin for the prevention of chicken pox—recommendations of the immunization practices advisory committee (ACIP). MMWR 33:84–100, 1984.

    Google Scholar 

  62. Uduman SA, Gershon AA, Brunell PA: Should patients with zoster receive zoster immune globulin? JAMA 234:1049–1051, 1975.

    Article  PubMed  CAS  Google Scholar 

  63. Jordan GW, Merigan TC: Cell-mediated immunity to varicella-zoster virus: In vitro lymphocyte responses. J Infect Dis 130:495–501, 1974.

    Article  PubMed  CAS  Google Scholar 

  64. Russell AS, Maini RA, Bailey M, et al: Cell-mediated immunity to varicella-zoster antigen in acute herpes zoster (shingles). Clin Exp Immunol 14:181–185, 1972.

    Google Scholar 

  65. Arvin AM, Pollard RB, Rasmussen LE, et al: Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma. J Infect Dis 137:531–539, 1978.

    Article  PubMed  CAS  Google Scholar 

  66. Gershon AA, Steinberg M, Smith M: Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactiva-tion with human leukocytes. Infect Immunol 13:1549–1553, 1976.

    CAS  Google Scholar 

  67. Kamiya H, Ihara T, Hattori A, et al: Diagnostic skin test reactions with varicella virus antigen and clinical application of the test. J Infect Dis 136:784–788, 1977.

    Article  PubMed  CAS  Google Scholar 

  68. Kirchner H: Herpes simplex virus and lymphocytes. In Proffitt M (ed): Virus-Lymphocyte Interactions. Implications for Disease. Elsevier, New York, 1979, pp. 259–266.

    Google Scholar 

  69. Norris FH Jr, Leonards R, Calanchini PR, et al: Herpeszoster meningoencephalitis. J Infect Dis 122:335–338, 1970.

    Article  PubMed  Google Scholar 

  70. Gershon A, Steinberg S, Greenberg S, et al: Varicella-zoster-associated encephalitis: Detection of specific antibody in cerebrospinal fluid. J Clin Microbiol 12:765–767, 1980.

    Google Scholar 

  71. Brunell P, Shehab Z, Geiser C, et al: Administration of live varicella vaccine to children with leukemia. Lancet 2:1069–1072, 1982.

    Article  PubMed  CAS  Google Scholar 

  72. Gershon AA, Steinberg SP, Gelb L, et al: Live attenuated varicella vaccine: Efficacy for children with leukemia in remission. JAMA 255:355–362, 1984.

    Article  Google Scholar 

  73. Weibel RE, Neff BJ, Kuter BJK, et al: Live attenuated varicella virus vaccine-efficacy trial in healthy children. N Engl J Med 310:1409–1415, 1984.

    Article  PubMed  CAS  Google Scholar 

  74. Whitley R, Hilty M, Haynes R, et al: Vidarabine therapy of varicella in immunosuppressed patients. J Pediatr 101:125–131, 1982.

    Article  PubMed  CAS  Google Scholar 

  75. Prober CG, Kirk LE, Keeney RE: Acyclovir therapy of chicken pox in immunosuppressed children—a collaborative study. J Pediatr 101:622–625, 1982.

    Article  PubMed  CAS  Google Scholar 

  76. Whitley RJ, Soong SJ, Dolin R, et al: Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med 307:971–975, 1982.

    Article  PubMed  CAS  Google Scholar 

  77. Whitley RJ, Chien LT, Dolin R, et al: Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID Collaborative Antiviral Study. N Engl J Med 294:1193–1194, 1976.

    Article  PubMed  CAS  Google Scholar 

  78. Balfour HH Jr, Bean B, Laskin OL, et al: Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 308:1448–1453, 1983.

    Article  PubMed  Google Scholar 

  79. Shepp DH, Dandliker PS, Meyers JD: Treatment of varicella-zoster virus infection in severely immunocompromised patients. N Engl J Med 314:208–212, 1986.

    Article  PubMed  CAS  Google Scholar 

  80. Merigan TC, Rand KH, Pollard RB, et al: Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med 298:981–987, 1978.

    Article  PubMed  CAS  Google Scholar 

  81. Arvin AM, Kushner JH, Feldman S, et al: Human leukocyte interferon for the treatment of varicella in children with cancer. N Engl J Med 306:761–765, 1982.

    Article  PubMed  CAS  Google Scholar 

  82. Ho M: Cytomegalovirus—Biology and Infection. Plenum, New York, 1982.

    Google Scholar 

  83. Plotkin SA, Michelson S, Pagano JS, Rapp F (eds): CMV: Pathogenesis and Prevention of Human Infection. Liss, New York, 1984.

    Google Scholar 

  84. Betts RF, Freeman RB, Douglas RG Jr, et al: Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child 131:759–763, 1977.

    PubMed  CAS  Google Scholar 

  85. Luby JP, Burnett W, Hull AR, et al: Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplantation. J Infect Dis 129:511–518, 1974.

    Article  PubMed  CAS  Google Scholar 

  86. Rubin RH, Cosimi AB, Tolkoff-Rubin NE, et al: Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation 24:458–464, 1977.

    Article  PubMed  CAS  Google Scholar 

  87. Broughton WL, Cupples HP, Parver LM: Bilateral retinal detachment following cytomegalovirus retinitis. Arch Ophthalmol 96:618–619, 1978.

    Article  PubMed  CAS  Google Scholar 

  88. Murray HW, Know DL, Green WR, et al: Cytomegalovirus

    Google Scholar 

  89. Dorfman LJ: Cytomegalovirus encephalitis in adults. Neurology (NY) 23:136–144, 1973.

    CAS  Google Scholar 

  90. Simmons RL, Lopez C, Balfour H, et al: Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg 180:623–632, 1974.

    Article  PubMed  CAS  Google Scholar 

  91. Suwansirikul S, Rao N, Dowling JN, et al: Primary and secondary cytomegalovirus infection: Clinical manifestations after renal transplantation. Arch Intern Med 137:1026–1029, 1977.

    Article  PubMed  CAS  Google Scholar 

  92. Rubin RH, Levin M, Cohen C, et al: Summary of workshop on cytomegalovirus infections during organ transplantation. J Infect Dis 139:728–734, 1979.

    Article  PubMed  CAS  Google Scholar 

  93. Meyers JD: Cytomegalovirus infection following marrow transplantation: Risk, treatment, and prevention. In Plotkin SA, Michelson S, Pagano JS, et al (eds): CMV: Pathogenesis and Prevention of Human Infection. Liss, New York, 1984, pp. 101–117.

    Google Scholar 

  94. Pollard RB, Egbert PR, Gallagher JG, et al: Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside. Ann Intern Med 93:655, 1980.

    PubMed  CAS  Google Scholar 

  95. Glenn J: Cytomegalovirus infections following renal transplantation. Rev Infect Dis 3:1151–1178, 1981.

    Article  PubMed  CAS  Google Scholar 

  96. Schooley RT, Hirsch MS, Colvin RB, et al: Association of herpesgroup virus infections with T-lymphocyte subset alterations, glomerulopathy, and opportunistic infections following renal transplantation. N Engl J Med 308:307–313, 1983.

    Article  PubMed  CAS  Google Scholar 

  97. Macher AM, Reichert CM, Straus SE, et al: Death in the AIDS patient: role of cytomegalovirus. N Engl J Med 309:1454, 1983.

    PubMed  CAS  Google Scholar 

  98. Friedman AH, Orellana J, Freeman WR, et al: Cytomegalovirus retinitis. A manifestation of the acquired immune deficiency syndrome (AIDS). Br J Ophthalmol 67:372–380, 1983.

    Article  PubMed  CAS  Google Scholar 

  99. Holland GN, Pepose JS, Pettit TH, et al: Acquired immune deficiency syndrome—ocular manifestations. Ophthalmology 90:859–873, 1983.

    PubMed  CAS  Google Scholar 

  100. Friedman HM, Grossman RA, Plotkin SA, et al: Relapse of pneumonia caused by cytomegalovirus in two recipients of renal transplants. J Infect Dis 139:465–473, 1979.

    Article  PubMed  CAS  Google Scholar 

  101. Simmons RL, Matas AJ, Rattazzi LC, et al: Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 82:537–546, 1977.

    PubMed  CAS  Google Scholar 

  102. Cheeseman SH, Stewart JA, Winkle S, et al: Cytomegalovirus excretion two to fourteen years after renal transplantation. Transplant Proc 9:71–74, 1979.

    Google Scholar 

  103. Richardson WP, Colvin RB, Cheeseman SH, et al: Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 305:57–63, 1981.

    Article  PubMed  CAS  Google Scholar 

  104. Tapper ML, Rotterdam HZ, Lerner CW, et al: Adrenal necrosis in the acquired immunodeficiency syndrome. Ann Intern Med 100:239–241, 1984.

    PubMed  CAS  Google Scholar 

  105. Quinnan GV Jr, Rook AH: The importance of cytotoxic cellular immunity in the protection from cytomegalovirus infection. In Plotkin SA, Michelson S, Pagano JS, et al (eds): CMV: Pathogenesis and Prevention of Human Infection. Liss, New York, 1984, pp. 245–261.

    Google Scholar 

  106. Hamilton JR, Overall JC Jr, Glasgow LA: Synergistic infection with murine cytomegalovirus and Candida albicans in mice. J Infect Dis 135:918–924, 1977.

    Article  PubMed  CAS  Google Scholar 

  107. Hamilton JR, Overall JC Jr.: Synergistic infection with murine cytomegalovirus and Pseudomonas aeruginosa in mice. J Infect Dis 137:775–782, 1978.

    Article  PubMed  CAS  Google Scholar 

  108. Hirsch MS: Cytomegalovirus-leukocyte interactions. In Plotkin SA, Michelson S, Pagano JS, et al (eds): CMV: Pathogenesis and Prevention of Human Infection. Liss, New York, 1984, pp. 161–173.

    Google Scholar 

  109. Chou S, Merigan TC: Rapid detection and quantitation of human cytomegalovirus in urine through DNA hybridization. N Engl J Med 308:921–925, 1983.

    Article  PubMed  CAS  Google Scholar 

  110. Spector SA, Rua JA, Spector DH: Detection of human cytomegalovirus in clinical specimens by DNA-DNA hybridization. J Infect Dis 150:121–126, 1984.

    Article  PubMed  CAS  Google Scholar 

  111. Volpi A, Whitley RJ, Ceballos R: Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis 147:1119–1120, 1983.

    Article  PubMed  CAS  Google Scholar 

  112. Winston DJ, Pollard RB, Ho WG, et al: Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med 97:11–18, 1982.

    PubMed  CAS  Google Scholar 

  113. Meyers JD, Leszczynski J, Zaia JA, et al: Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 98:442–446, 1983.

    PubMed  CAS  Google Scholar 

  114. Plotkin SA, Smiley ML, Friedman HM, et al: Towne-vac-cine-induced prevention of cytomegalovirus disease after renal transplants. Lancet 1:528–530, 1984.

    Article  PubMed  CAS  Google Scholar 

  115. Hirsch MS, Schooley RT, Cosimi AB, et al: Effects of interferon alpha on cytomegalovirus reactivation syndromes in renal transplant recipients—results of a placebo controlled trial. N Engl J Med 308:1489–1493, 1983.

    Article  PubMed  Google Scholar 

  116. Meyers JD, McGuffin RW, Bryson YJ, et al: Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis 146:80–84, 1982.

    Article  PubMed  CAS  Google Scholar 

  117. Felsenstein D, D’Amico D, Hirsch MS, et al: Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxy-methyl)ethoxymethyl]guanine (BWB759U). 103:377–80, 1985.

    CAS  Google Scholar 

  118. Collaborative DHPG Treatment Study Group: Treatment of serious cytomegalovirus infections with 9-(l ,3 dihydroxy-2-propoxymethyOguanine in patients with AIDS and other immunodeficiencies. New Engl J Med 314:801–805, 1986.

    Article  Google Scholar 

  119. Grose C, Henle W, Henle G, et al: Primary Epstein-Barr virus infections in acute neurologic diseases. N Engl J Med 292:392–395, 1975.

    Article  PubMed  CAS  Google Scholar 

  120. Klein G: The relationship of the virus to nasopharyngeal carcinoma. In Epstein MA, Achong BG (eds): The Epstein-Barr Virus. Springer-Verlag, Berlin, 1979, pp. 339–350.

    Chapter  Google Scholar 

  121. Epstein MA, Achong BG: The relationship of the virus to Burkitt’s lymphoma. In Epstein MA, Achong BG (eds): The Epstem-Barr Virus. Springer-Verlag, Berlin, 1979, pp. 321–37.

    Chapter  Google Scholar 

  122. Hochberg FH, Miller G, Schooley RT, et al: Central nervous system lymphoma related to Epstein-Barr virus. N Engl J Med 309:745–748, 1983.

    Article  PubMed  CAS  Google Scholar 

  123. Strauch B, Siegel N, Andrews LL, et al: Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet 1:234–237, 1974.

    Article  PubMed  CAS  Google Scholar 

  124. Chang RS, Lewis JP, Reynolds RD, et al: Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann Intern Med 88:34–40, 1978.

    PubMed  CAS  Google Scholar 

  125. Lange B, Arbeiter A, Hewetson J: Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin’s disease. Int J Cancer 22:521–527, 1978.

    Article  PubMed  CAS  Google Scholar 

  126. Cheeseman SH, Henle W, Rubin RH, et al: Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon. Ann Intern Med 193:39–42, 1980.

    Google Scholar 

  127. Grose C, Henle W, Horwitz MS: Primary Epstein-Barr virus infection in a renal transplant recipient. South Med J 70:1276–1278, 1977.

    Article  PubMed  CAS  Google Scholar 

  128. Marker SC, Ascher NL, Kalis JM, et al: Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery 85:433–440, 1978.

    Google Scholar 

  129. Crawford DH, Thomas JA, Janossy G: Epstein-Barr virus nuclear antigen-positive lymphoma after cyclosporin-A treatment in patients with renal allograft. Lancet 1:1355–1356, 1980.

    Article  PubMed  CAS  Google Scholar 

  130. Cleary ML, Sklar J: Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 2:489–494, 1984.

    Article  PubMed  CAS  Google Scholar 

  131. Hanto DW, Frizzera G, Gajl Peczalska KJ, et al: Epstein-Barr virus induced B-cell lymphoma after renal transplantation. Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 306:913–918, 1982.

    Article  PubMed  CAS  Google Scholar 

  132. Ziegler JL, Miner RC, Rosenbaum E, et al: Outbreak of Burkitt’s-like lymphoma in homosexual men. Lancet 1:631–633, 1982.

    Article  Google Scholar 

  133. Ziegler JL, Beckstead JA, Volberding PA, et al: Non-Hodgkin’s lymphoma in 90 homosexual men: relationship to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565–570, 1984.

    Article  PubMed  CAS  Google Scholar 

  134. Sullivan JL, Byron JS, Brewster FE, et al: X-linked lymphoproliferative syndrome: natural history of the immunodeficiency. J Clin Invest 71:1765–1778, 1983.

    Article  PubMed  CAS  Google Scholar 

  135. Purtilo DT, Sakamoto KB, Barnabei V, et al: Epstein-Barr virus-induced diseases in boys with the X-linked lympho-proliferative syndrome—update on studies of the registry. Am J Med 73:49–56, 1982.

    Article  PubMed  CAS  Google Scholar 

  136. Sixbey JW, Nedrud JG, Raab-Traub N, et al: Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225–1230, 1984.

    Article  PubMed  CAS  Google Scholar 

  137. Robinson J, Miller G: Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood. J Virol 15:1065–1071, 1975.

    PubMed  CAS  Google Scholar 

  138. Pattengale PK, Smith RW, Perlin E: Atypical lymphocytes in acute infectious mononucleosis. N Engl J Med 291:1145–1148, 1914.

    Article  Google Scholar 

  139. Crawford DH, Sweny P, Edwards JMB, et al: Long-term T-cell-mediated immunity to Epstein-Barr virus in renal allograft recipients receiving cyclosporin A. Lancet 1:10–13, 1981.

    Article  PubMed  CAS  Google Scholar 

  140. Sullivan JL, Byron KS, Brewster FE, et al: Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 210:543–545, 1980.

    Article  PubMed  CAS  Google Scholar 

  141. Lindsten T, Seeley JK, Ballow M, et al: Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immu-noregulatory T cell defects. J Immunol 129:2536–2540, 1982.

    PubMed  CAS  Google Scholar 

  142. Ochs HD, Sullivan JL, Wedgwood RJ, et al: X-linked lymphoproliferative syndrome: Abnormal antibody responses to bacteriophage. Birth Defects 19:321–323, 1983.

    PubMed  CAS  Google Scholar 

  143. Britton S, Andersson-Anvret M, Gergely P: Epstein-Barr virus immunity and tissue distribution in a fatal case of infectious mononucleosis. N Engl J Med 298:89–92, 1978.

    Article  PubMed  CAS  Google Scholar 

  144. Adams A, Strander H, Cantell K: Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon. J Gen Virol 28:207–217, 1975.

    Article  PubMed  CAS  Google Scholar 

  145. Coker-Vann M, Dolin R: Effect of adenine arabinoside on Epstein-Barr virus in vitro. J Infect Dis 135:447–453, 1977.

    Article  PubMed  CAS  Google Scholar 

  146. Datta AK, Colby BM, Shaw JE, et al: Acyclovir inhibition of Epstein-Barr virus replication. Proc Natl Acad Sci USA 77:5163–5166, 1980.

    Article  PubMed  CAS  Google Scholar 

  147. Garner JG, Hirsch MS, Schooley RT: Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha. Infect Immun 43:920–924, 1984.

    PubMed  CAS  Google Scholar 

  148. Lin JC, Smith MC, Pagano JS: Prolonged inhibitory effect of 9-(l,3-dihydroxy-2-propoxy methyl)guanine against replication of Epstein-Barr virus. J Virol 50:50–55, 1984.

    PubMed  CAS  Google Scholar 

  149. Salahuddin SZ, Ablashi Dv, Markham PD, et al: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596–601, 1986.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Disease Unit, Massachusetts General Hospital; and Department of Medicine, Harvard Medical School, Boston, Massachusetts, 02114, USA

    Martin S. Hirsch

Authors
  1. Martin S. Hirsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Infectious Disease and Transplantation Units, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

    Robert H. Rubin M.D.

  2. Division of Infectious Diseases, Pacific Presbyterian Medical Center, Kuzell Institute for Arthritis and Infectious Diseases, San Francisco, California, USA

    Lowell S. Young M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Publishing Corporation

About this chapter

Cite this chapter

Hirsch, M.S. (1988). Herpes Group Virus Infections in the Compromised Host. In: Rubin, R.H., Young, L.S. (eds) Clinical Approach to Infection in the Compromised Host. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6642-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6642-7_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-6644-1

  • Online ISBN: 978-1-4615-6642-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation